Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
7.193T
Market Weight
9.35%
Industries
11
Companies
1177
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare
Day Return
Sector
0.39%
S&P 500
0.19%
YTD Return
Sector
13.90%
S&P 500
16.31%
1-Year Return
Sector
8.15%
S&P 500
12.88%
3-Year Return
Sector
12.87%
S&P 500
68.74%
5-Year Return
Sector
28.80%
S&P 500
86.09%
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 13.90% | |
| Drug Manufacturers - General | 37.26% | 24.39% | |
| Biotechnology | 12.96% | 33.19% | |
| Medical Devices | 12.42% | 8.28% | |
| Diagnostics & Research | 11.05% | 13.53% | |
| Healthcare Plans | 8.52% | -20.37% | |
| Medical Instruments & Supplies | 6.95% | -1.35% | |
| Medical Care Facilities | 3.14% | 24.28% | |
| Medical Distribution | 3.07% | 40.13% | |
| Drug Manufacturers - Specialty & Generic | 2.55% | 8.25% | |
| Health Information Services | 2.08% | 5.03% | |
| Pharmaceutical Retailers | 0.01% | -95.47% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
Day Return --
Market Weight --
YTD Return --
Drug Manufacturers - General
-0.71%
Biotechnology
0.19%
Medical Devices
-0.27%
Diagnostics & Research
-0.61%
Healthcare Plans
-0.96%
Medical Instruments & Supplies
0.89%
Medical Care Facilities
-0.43%
Medical Distribution
-0.39%
Drug Manufacturers - Specialty & Generic
Health Information Services
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 1,056.70 | 12.78% | | | | Buy | |
| | 203.42 | 6.86% | | | | Buy | |
| | 243.55 | 5.64% | | | | Buy | |
| | 388.52 | 4.23% | | | | Buy | |
| | 106.62 | 3.51% | | | | Buy | |
| | 144.43 | 3.07% | | | | Buy | |
| | 619.96 | 3.04% | | | | Buy | |
| | 596.36 | 2.91% | | | | Buy | |
| | 324.25 | 2.51% | | | | Buy | |
| | 255.67 | 2.29% | | | | Strong Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.837B | 0.08% | | |
| | 20.362B | 0.09% | | |
| | 8.796B | 0.44% | | |
| | 8.335B | 0.35% | | |
| | 4.508B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.576B | 0.32% | | |
| | 40.576B | 0.32% | | |
| | 20.362B | 0.09% | | |
| | 14.462B | 0.00% | | |
| | 14.462B | 0.00% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Guardant Health, Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
RatingPrice TargetAnalyst Report: The Cooper Companies, Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice TargetAnalyst Report: The Cooper Companies, Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice TargetDaily – Vickers Top Insider Picks for 12/05/2025
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
